Brenda Coleman specialises in all aspects of corporate tax including private equity, fund formation, public and private M&A, restructurings, complex financings and tax disputes. Her experience includes acting for private equity funds, multi-asset managers, LPs, multinational companies, banks, hedge funds, Sovereign wealth funds and various UK Government departments.

Brenda is described in Chambers UK 2022 as “extremely capable, very analytical and very thorough.” Clients say “she is easy to work with, technically solid and commercially oriented.” Brenda’s clients are further quoted in The Legal 500 UK, describing her as “a leading figure, highly technical yet very pragmatic,” and “very pleasant to work with, smart, lots of experience and hands on practical advice.” She has been selected for the Hall of Fame by The Legal 500. In 2022 she was named “Lawyer of the Year” for Tax Law in London by The Best Lawyers in the UK (having been recognised by Best Lawyers since 2009).


  • 3i Group plc, a leading international investment manager focused on mid-market private equity and infrastructure, and GartenHaus on the acquisition of Outdoor Toys, one of the UK’s leading online retailers of outdoor garden toys 
  • ERM, the world’s largest pure-play sustainability consultancy, and the ERM Partner shareholders, on the sale of ERM to KKR, a leading global investment firm
  • Inflexion and other shareholders (including the management team) on the sale of Reed & Mackay, a premium corporate travel management and events business, to TripActions, a U.S.-headquartered business travel and spend management platform
  • SC Health Corp., a special purpose acquisitions company, in its proposed merger with Rockley Photonics, Ltd, a leading integrated photonics chipset developer and module supplier for high-volume sensor and communication products 
  • Envision Pharma Group, a portfolio company of GHO Capital Partners, on its acquisition of Two Labs, an industry-leading provider of integrated and customized commercial solutions to the pharmaceutical and biotechnology sector 
  • 3i Group plc on its c. £125 million investment alongside management for a majority stake in MPM, an international leader in branded, premium, natural pet food 
  • GHO Capital Partners on its acquisition (alongside the existing Envision management team and employees) of a majority stake in Envision Pharma Group, a leading technology-enabled scientific communications company’ 
  • Averna Capital on its investment in ClimateCare, a leading profit with purpose environmental and social impact company headquartered in Oxford, UK 
  • Sound United LLC, a portfolio company of Charlesbank Capital Partners, on its acquisition of Bowers & Wilkins, a leading designer and manufacturer of luxury home audio speakers, headphones, custom installation products, wireless speakers, and branded audio systems in the automotive and television markets
  • Arsenal Capital Partners on the proposed acquisition by its portfolio company Value Demonstration Holdings LLC of Cello Health plc, an AIM-listed global healthcare-focused advisory group 
  • Welsh, Carson, Anderson & Stowe on its public to private acquisition of Abzena plc, a UK-based biopharmaceutical services company
  • Avista Capital Partners on its 305m Joint Acquisition of Vision Healthcare, one of Europe’s fastest-growing omni-channel and direct-to-consumer health care companies
  • Bain Capital on its acquisition of:
    • a controlling stake in MKM, the UK’s largest independent builders’ merchant; 
    • NGA UK, a UK payroll and HR Business from NGA Human Resources; and 
    • CRH plc’s clay and concrete business in the UK and the U.S.
  • CCMP on its sale of PureGym, a chain of no frills fitness clubs in the UK
  • Charlesbank Capital Partners and Ensono on the acquisition of a data centre business from Wipro
  • TSG Consumer Partners on its acquisition of a minority stake in BrewDog, a Scottish craft beer
  • 3i Group plc on the acquisition of Audley Travel
  • Epiris on its acquisition of Bonhams
  • Genstar Capital on its (approx.) $1bn acquisition of CRF Health
  • ICG in the $5.3bn consortium buy-out of Visma
  • ICG on its £1.3bn joint partnership investment into IRIS
  • Ares Management on the sale of its portfolio company Cordium 
  • Northern European private equity sponsor in the formation of its €4.25 billion Northern Europe focused private equity fund
  • APG on its acquisition of a 75 per cent interest in a joint venture with TH Real Estate, to develop the St James Centre in Edinburgh, one of the UK’s largest private regeneration projects

Areas of Practice


    Ropes & Gray International LLP is a limited liability partnership registered in Delaware, United States of America and is a recognised body regulated by the Solicitors Regulation Authority (with registered number 521000).